Catalysts
EW Stock Catalysts
Earnings · Growth Drivers · Events · AIQ Catalyst
EW
CatalystsStock Catalyst Board
Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.
Upcoming reporting date available for this company.
Momentum 56/100 and sentiment — before the next covered event.
Updated Sep 6, 2026 · Sentiment 29.38%
Earnings History And Surprises
See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.
Earnings Expectations And Results
Compare what analysts expected with what the company reported across recent quarters.
| Report date | Fiscal period | EPS estimate | EPS actual | EPS surprise | Revenue estimate | Revenue actual |
|---|---|---|---|---|---|---|
| Jul 23, 2026 | — | $0.74 | $0.78 | +5.0% | $1.7B | $1.74B |
| Apr 23, 2026 | — | $0.73 | $0.78 | +7.0% | $1.6B | $1.65B |
| Feb 10, 2026 | — | $0.62 | $0.58 | -6.1% | $1.55B | $1.57B |
| Oct 30, 2025 | — | $0.60 | $0.67 | +12.4% | $1.5B | $1.55B |
| Jul 24, 2025 | — | $0.62 | $0.67 | +7.4% | $1.49B | $1.53B |
| Apr 23, 2025 | — | $0.60 | $0.64 | +7.4% | $1.4B | $1.41B |
| Feb 11, 2025 | — | $0.55 | $0.59 | +7.1% | $1.36B | $1.39B |
| Oct 24, 2024 | — | $0.67 | $0.67 | +0.8% | $1.54B | $1.35B |
Analyst Forecast And Price Targets
Wall Street consensus, rating distribution, and the current 12-month target range.
Event Read
Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.
Current event setup
Next known earnings or reporting date.
Current analyst expectation for the upcoming report.
Current analyst expectation for the upcoming report.
News pressure around the setup.
Where event reaction would show up first.
Composite decision read before event confirmation.
Analyst context
News And Sentiment
Recent company coverage, scored where source sentiment is available.
Edwards Lifesciences (EW): The Medical Device Leader Behind the TAVR Boom
Aristotle Capital Management, LLC, an investment management company, released its “Value Equity Fund” Q2 2026 investor letter. A copy of the letter can be downloaded here. The Fund delivered a 4.32% total return in Q2 2026, underperforming the 13.87% gain for the Russell 1000 Value Index and the 15.20% return for the S&P 500, while […]
Edwards Lifesciences (EW) Has a Growth Runway Competitors May Struggle to Match
Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here. The Fund gained 11.99% during the quarter, compared with the 10.48% gain for the Russell 3000 Health Care Index and the 15.44% gain for the Russell 3000 Index. Since inception, […]
Related Links
EW Catalysts FAQ
What are the next catalysts for EW stock?
EW's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.
What upcoming events could move EW stock?
Upcoming events that could move EW include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.
How could EW's next earnings report affect the stock?
EW's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.
What could drive EW stock higher?
EW could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.
What events could hurt EW stock?
EW could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.